News

Do you have Nontuberculous
Mycobacterial (NTM) Pulmonary Disease?

Use pre-paid cards to support NTMir!

You can do your everyday shopping and great gift-giving while supporting NTM Info & Research! NTMir is able to sell gift cards with no activation fees to major national and regional retailers. In return, the retailers donate a percentage back to our...

Read More

UPDATE: FDA Decision on Linhaliq

Aradigm, the company that submitted Linhaliq to the FDA for approval, announced that they had received a complete response letter (CRL) from the FDA stating that they would not approve the treatment at this time. Many of you have communicated recently with the FDA...

Read More

Tips on Writing to the FDA

The voice of the patient has a role in the drug development and approval process. In fact, recent legislation mandates an increased emphasis on incorporating the patient perspective into the drug approval process.

Read More

The Bronchiectasis and NTM Information Line is now open!

NTM Info & Research and the COPD Foundation is happy to announce the release of the Bronchiectasis and NTM Information Line: 1-833-411-LUNG (5864). The Bronchiectasis and NTM Information Line is a toll-free number managed by the C.O.P.D. Information Line for...

Read More

Support Group Corner

Support Groups come in many different forms. Some are large, some small, some meet monthly, some meet only a few times per year, some meet in person, some are on-line only. There are no rules. We would like to introduce you to a group that has found an innovative...

Read More

Reflections on Our Physician/Patient Conference

Our continuing education-accredited conference is a groundbreaking opportunity for health care providers, researchers, patients, families, and caregivers to learn about the latest advances in research, treatment, and care from leaders in the field of nontuberculous...

Read More

NTMir Presents Research at ATS 2016

At the American Thoracic Society International Conference in May, Amy Leitman from NTM Info & Research, along with Dr. Mehdi Mirsaeidi from the University of Miami, presented the results of a survey on geographic diversity of nontuberculous mycobacteria species...

Read More

NTM Patient Preferences Survey

On April 8th, 2019 the U.S. Food & Drug Administration will host a public workshop on the development of antibacterial drugs for the treatment of nontuberculous mycobacterial (NTM)...

Read More

220000

ESTIMATED CASES
OF NTM IN THE US
IN 2020

8.2 %

THE RISE IN THE
NUMBER OF NTM CASES
EACH YEAR

2.8m

ANTIBIOTIC-
RESISTANT INFECTIONS
IN THE US EACH YEAR